Company news
EMvision Medical Devices Ltd. news in 2025
EMvision Medical Devices Ltd.'s news releases, calls and decks from 2025, newest first.
First Responder Aeromedical Study Commences
November 26, 2025
Oversubscribed SPP Raises $2.0M
October 31, 2025
Oversubscribed SPP To Close Early
October 21, 2025
$3m CRC-P Grant Executed & First Payment Received
October 13, 2025
SPP Offer Document & Option Prospectus
September 28, 2025
Pre-Hospital MSU Study Commences with First Responder Device
September 23, 2025
Firm Commitments for $12.0M Placement & Launch of SPP
September 16, 2025
Trading Halt
September 15, 2025
Appendix 4E & Annual Report to 30 June 2025
August 27, 2025
UCLA Health Activation & Continuous Innovation Study Update
August 25, 2025
EMVision Awarded $3m Grant For Regional Benefits Study
August 14, 2025
First Responder Program Advanced & Grant Milestone Achieved
July 28, 2025
Key Developments in Pivotal Trial & Innovation Study
July 1, 2025
EMVision Awarded $5m Non-Dilutive Government Grant
June 15, 2025
Additional Pivotal Trial Site Activations
June 2, 2025
Enhanced Algorithm Performance From Continuous Innovation
May 20, 2025
Activation of Second US Pivotal Trial Site, Mayo Clinic
April 27, 2025
Emu Pivotal Validation Trial Commences
March 26, 2025
First Responder Scanner in Successful Aeromedical Testing
March 18, 2025
S&P DJI Announces March 2025 Quarterly Rebalance
March 7, 2025
EMVision Releases its FY25 Half Yearly Report
February 27, 2025
US Ethics Approval Received for Pivotal Validation Trial
February 11, 2025
EMVision Receives $2.12m R&D Tax Rebate
January 19, 2025
Decks in 2025
- Shareholder Meeting (November 2025)
Shareholder meeting · 22 slides · Nov 11, 2025
- Investor Presentation (September 2025)
Investor deck · 40 slides · Sep 17, 2025
- E&P Small Cap Healthcare Conference (September 2025)
Conference · 32 slides · Sep 9, 2025